Abstract
Alzheimer’s disease (AD) is the most common form of dementia in adults. It determines a progressive loss of intellectual function and appears both sporadically and in an autosomal dominant (familial) form. Presently there is no treatment for AD.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC et al. (1993): Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science 261:921–923
Kindy MS, King AR, Perry G, De Beer MC and De Beer FC (1995): Association of apolipoprotein E with murine amyloid A protein amyloid. Lab Invest 73:469–475.
Kisilevsky R, Lemieux LJ, Fraser PE, Kong X, Hultin PG et al. (1995): Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: implications for Alzheimer’s disease. Nature Med 1:143–148.
Lorenzo A and Yankner BA (1994): Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. Proc Natl Acad Sci USA 91:12243–12247.
Ma J, Yee A, Brewer HB, Jr., Das S and Potter H (1994): Amyloid-associated proteins alpha 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer beta-protein into filaments. Nature 372:92–94.
Maggio JE, Stimson ER, Ghilardi J, Allen CJ, Dahl CE et al. (1992): Reversible in vitro growth of Alzheimer’s disease β-amyloid plaques by deposition of labeled amyloid peptide. Proc Natl Acad Sci USA 89:5462–5466.
Matsubara E, Soto C, Governale S, Frangione B and Ghiso J (1996): Apolipoprotein J and Alzheimer amyloid solubility. Biochem J (In Press)
Merlini G, Ascari E, Amboldi N, Belloti V, Arbustini E et al. (1995): Interaction of the anthracycline 4’-iodo-4’-deoxydoxorubicin with amyloid fibrils: Inhibition of fibrillogenesis. Proc Natl Acad Sci USA 92:2959–2964.
Naslund J, Thyberg J, Tjernberg LO, Wernstedt C, Karlstrom AR et al. (1995): Characterization of stable complexes involving apolipoprotein E and the amyloid beta peptide in Alzheimer’s disease brain. Neuron 15:219–228.
Pike CJ, Burdick D, Walencewicz AJ, Glabe CG and Cotman CW (1993): Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state. J Neurosci 13:1676–1687.
Sisodia SS and Price DL (1995): Role of the β-amyloid protein in Alzheimer’s disease. FASEB J 9:366–370.
Snow AD, Bramson R, Mar H, Wight TN and Kisilevsky R (1991): A temporal and ultrastructural relationship between heparan sulphate proteoglycans and AA amyloid in experimental amyloidosis. J Histochem Cytochem 39:1321–1330.
Soto C, Castaño EM, Frangione B and Inestrosa NC (1995): The alpha-helical to beta-strand transition in the amino-terminal fragment of the amyloid beta-peptide modulates amyloid formation. J Biol Chem 270:3063–3067.
Soto C, Golabek AA, Wisniewski T and Castaño EM (1996): Amyloid β-peptide is conformationally modified by apolipoprotein E in vitro. Neuroreport (In Press)
Wisniewski T, Castaño EM, Golabek A, Vogel T and Frangione B (1994a): Acceleration of Alzheimer’s fibril formation by apolipoprotein E in vitro. Am J Pathol 145:1030–1035.
Wisniewski T, Ghiso J and Frangione B (1994b): Alzheimer’s disease and soluble A. Neurobiol Aging 15:143–152.
Wisniewski T, Lalowski M, Golabek A, Vogel T and Frangione B (1995): Is Alzheimer’s disease an apolipoprotein E amyloidosis? Lancet 345:956–958.
Wisniewski T and Frangione B (1992): Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci Lett 135:235–238.
Wood JD, Wetzel R, Martin JD and Hurle MR (1995): Prolines and amyloidogenicity in fragments of the Alzheimer’s peptide β/A4. Biochem 34:724–730.
Wouters MA and Curmi PMG (1994): An analysis of side chain interactions and pair correlations within antiparallel beta-sheets: the differences between backbone hydrogen-bonded and non-hydrogen bonded residue pairs. Protein Sci 3:43S.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Birkhäuser Boston
About this chapter
Cite this chapter
Soto, C., Prelli, F., Frangione, B., Kindy, M.S., de Beer, F. (1997). Peptides Inhibitor of Amyloidogenesis in Alzheimer’s Disease. In: Becker, R.E., Giacobini, E., Barton, J.M., Brown, M. (eds) Alzheimer Disease. Advances in Alzheimer Disease Therapy. Birkhäuser Boston. https://doi.org/10.1007/978-1-4612-4116-4_15
Download citation
DOI: https://doi.org/10.1007/978-1-4612-4116-4_15
Publisher Name: Birkhäuser Boston
Print ISBN: 978-1-4612-8660-8
Online ISBN: 978-1-4612-4116-4
eBook Packages: Springer Book Archive